Société Internationale d'Urologie

全身性強皮症と全身性エリテマトーデスがみられたオーバーラップ症候群を背景に転移性尿路上皮癌を発症した患者に対しペムブロリズマブ治療が奏効した1例(Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus), IJU Case Reports, 3(5) 181-183, 2020.09

Kurokawa Masayuki, Naito Sei, Ito Suguru, Takai Satoshi, Kawamura Yuko, Kaneko Hisashi, Kakizaki Hiroshi, Tsuchiya Norihiko

Single Author

国内多施設による75歳以上の腎細胞癌患者に対するニボルマブの有効性と安全性(Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes), International Journal of Clinical Oncology, 25(8) 1543-1550, 2020.08

Numakura Kazuyuki, Kobayashi Mizuki, Hatakeyama Shingo, Naito Sei, Horikawa Yohei, Tanaka Toshikazu, Kamada Sachiko, Muto Yumina, Yamamoto Ryohei, Koizumi Atsushi, Nara Taketoshi, Kanda Sohei, Saito M...

Single Author

同時性転移性腎細胞癌の新規予後モデル(New prognostic model for synchronous metastatic renal cell carcinoma), International Journal of Urology, 27(5) 448-456, 2020.05

Naito Sei, Kato Tomoyuki, Ichiyanagi Osamu, Narisawa Takafumi, Kurokawa Masayuki, Yagi Mayu, Ushijima Masaki, Ozawa Michinobu, Kanno Hidenori, Kurota Yuta, Fukuhara Hiroki, Kuboki Yuya, Yamagishi Atsu...

Single Author

周術期抗凝固療法非実施下で生体腎移植を施行されたヘパリン起因性血小板減少症の1例(Living kidney transplantation without perioperative anticoagulation therapy for a patient with heparin-induced thrombocytopenia), IJU Case Reports, 3(3) 86-89, 2020.05

Nishida Hayato, Fukuhara Hiroki, Yamagishi Atsushi, Hosoya Noriyuki, Ichiyanagi Osamu, Sakurai Toshihiko, Naito Sei, Yamanobe Takuya, Kato Tomoyuki, Tsuchiya Norihiko

Single Author

GPI-80は骨髄細胞不均一性の有用な指標であり、転移性腎細胞癌の予後予測バイオマーカーである(GPI-80 as a Useful Index for Myeloid Cell Heterogeneity and a Potential Prognostic Biomarker for Metastatic Renal Cell Carcinoma), The Tohoku Journal of Experimental Medicine, 249(3) 203-212, 2019.11

Kato Tomoyuki, Takeda Yuji, Ito Hiromi, Kurota Yuta, Yamagishi Atsushi, Sakurai Toshihiko, Naito Sei, Araki Akemi, Nara Hidetoshi, Asao Hironobu, Tsuchiya Norihiko

Single Author

AN EXPERIENCE OF PARTIAL NEPHRECTOMY IN A PATIENT WITH VON WILLEBRAND DISEASE, The Japanese Journal of Urology, 110(3) 196-200, 2019

Ito Suguru, Naito Sei, Shibasaki Tomohiro, Kawazoe Hisashi, Ichiyanagi Osamu, Kato Tomoyuki, Nagaoka Akira, Tsuchiya Norihiko, Kabasawa Takanobu, Aizawa Keiko, Ishizawa Kenji, Yamagishi Atsushi, Kurok...

Single Author

Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study, INTERNATIONAL JOURNAL OF UROLOGY, 33(1) e70281, 2026.01

Sazuka, T; Tatsugami, K; Shirotake, S; Hamamoto, S; Nozawa, M; Numakura, K; Mizokami, A; Kondo, T; Naito, S; Abe, T; Ohba, K; Kimura, G; Onodera, S; Yamaguchi, K; Uemura, H

Single Author

Bladder Amyloidosis With Pulmonary Lesions: A Case of Spontaneous Remission After Transurethral Resection, IJU CASE REPORTS, 9(1) e70123, 2025.12

Ito, S; Suzuki, T; Sato, R; Maeda, K; Suenaga, S; Kanno, H; Sato, S; Horie, S; Naito, S; Tsuchiya, N

Single Author

JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan, ESMO REAL WORLD DATA AND DIGITAL ONCOLOGY, 10 , 2025.12

Kitamura, H; Kobayashi, T; Endo, Y; Ikeda, M; Yonemori, K; Nakayama, M; Fujihara, A; Abe, T; Shimizu, F; Fujimoto, K; Nakagawa, T; Hatakeyama, S; Murakami, K; Nishihara, K; Ikarashi, D; Masumori, N; N...

Single Author

A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS), CURRENT ONCOLOGY, 32(11) , 2025.11

Ikeda, M; Fujimoto, K; Miura, N; Taoka, R; Nishihara, K; Ikarashi, D; Naito, S; Shimizu, F; Fujihara, A; Shono, M; Nakagawa, T; Kikuchi, E

Single Author

Robot-assisted laparoscopic radical prostatectomy for leiomyosarcoma of the prostate: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 135 111824, 2025.10

Nishida, H; Kanno, H; Fukuhara, H; Naito, S; Kabasawa, T; Tsuchiya, N

Single Author

Metabolic landscape of clear cell renal cell carcinoma and search for metabolites predictive of drug response, BMC CANCER, 25(1) 1357, 2025.08

Ozawa, M; Naito, S; Makinoshima, H; Ito, H; Tsuya, A; Narisawa, T; Fukuhara, H; Takai, Y; Ushijima, M; Yagi, M; Nishida, H; Tsuchiya, N

Single Author

The Effectiveness and Safety Profile of Nivolumab-Plus-Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J-ENCORE Study), INTERNATIONAL JOURNAL OF UROLOGY, 32(8) 961-972, 2025.08

Nishimoto, K; Kimura, G; Sazuka, T; Hamamoto, S; Nozawa, M; Numakura, K; Mizokami, A; Kondo, T; Naito, S; Abe, T; Ohba, K; Nagata, M; Onodera, S; Ito, H; Uemura, H

Single Author

Association Between Overactive Bladder and Sarcopenia in Older Adults: A Population-Based Cohort Study, INTERNATIONAL JOURNAL OF UROLOGY, 32(8) 1016-1022, 2025.08

Ito, S; Yagi, M; Sakurada, K; Naito, S; Nishida, H; Yamagishi, A; Kanno, H; Narisawa, T; Fukuhara, H; Takai, Y; Takai, S; Konta, T; Nagase, S; Tsuchiya, N

Single Author

MONOCYTIC MYELOID-DERIVED SUPPRESSOR CELLS EXHIBIT PRIMARY RESISTANCE TO NIVOLUMAB PLUS IPILIMUMAB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA, JOURNAL OF UROLOGY, 213(5S) , 2025.05

Numakura, K; Sobu, R; Kashima, S; Tokairin, O; Sekine, Y; Ohkubo, K; Mori, K; Kobayashi, M; Naito, S; Osawa, T; Tsuchiya, N; Shinohara, N; Habuchi, T

Single Author

Ankrd1 Promotes Lamellipodia Formation and Cell Motility via Interaction with Talin-1 in Clear Cell Renal Cell Carcinoma, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(9) , 2025.04

Takai, Y; Naito, S; Ito, H; Horie, S; Ushijima, M; Narisawa, T; Yagi, M; Ichiyanagi, O; Tsuchiya, N

Single Author

Ankrd1 enhances lamellipodia formation and cell motility in clear cell renal cell carcinoma, CANCER RESEARCH, 85(8) , 2025.04

Ito, H; Takai, Y; Naito, S; Narisawa, T; Tsuchiya, N

Single Author

Stress-induced sympathetic stimulation inhibits sorafenib-induced ferroptosis in renal cell carcinoma, CANCER RESEARCH, 85(8) , 2025.04

Ushijima, M; Naito, S; Ito, H; Ichiyanagi, O; Narisawa, T; Tsuchiya, N

Single Author

Coefficient variation of glycosylphosphatidylinositol-anchored 80 kDa protein (GPI-80) on neutrophil status in metastatic renal cell carcinoma (MRCC) patients treated with combination therapy of nivolumab plus ipilimumab, CANCER RESEARCH, 85(8) , 2025.04

Naito, S; Takeda, Y; Saima, S; Ito, H; Kato, T; Narisawa, T; Takai, Y; Suenaga, S; Yagi, M; Asao, H; Tsuchiya, N

Single Author

Characteristics of patients with metastatic renal cell carcinoma who do not respond to axitinib treatment, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 30(4) 781-788, 2025.04

Ohba, K; Osawa, T; Kojima, T; Hara, T; Sugimoto, M; Eto, M; Minami, K; Nakai, Y; Ueda, K; Naito, S; Nonomura, N; Murai, S; Nishiyama, H; Nakanishi, H; Mukae, Y; Mitsunari, K; Matsuo, T; Imamura, R; Sh...

Single Author

Urinary continence outcomes after robot-assisted laparoscopic radical prostatectomy: Significance of anterior reconstruction, INTERNATIONAL JOURNAL OF UROLOGY, 32(4) 355-360, 2025.04

Funajima, K; Naito, S; Fukai, A; Narisawa, T; Fukuhara, H; Suenaga, S; Takai, Y; Takai, S; Yagi, M; Kanno, H; Yamagishi, A; Nishida, H; Tsuchiya, N

Single Author

Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations, BMC CANCER, 25(1) 117, 2025.01

Kikuta, M; Naito, S; Osawa, T; Numakura, K; Narisawa, T; Takai, Y; Yagi, M; Sekine, Y; Tokairin, O; Shinohara, N; Habuchi, T; Tsuchiya, N

Single Author

Herpes zoster development in living kidney transplant recipients receiving low-dose rituximab, INTERNATIONAL JOURNAL OF UROLOGY, 32(1) 88-93, 2025.01

Nishida, H; Fukuhara, H; Takai, S; Nawano, T; Takehara, T; Narisawa, T; Kanno, H; Yagi, M; Yamagishi, A; Naito, S; Tsuchiya, N

Single Author

The functions of YAP in clear cell renal cell carcinoma and its association with HIF, CANCER SCIENCE, 116 1663, 2025.01

Takai, Y; Ito, H; Narisawa, T; Naito, S; Tsuchiya, N

Single Author

Effect of subutoclax in renal cell carcinoma, CANCER SCIENCE, 116 1662, 2025.01

Yagi, M; Naito, S; Ito, H; Takai, Y; Narisawa, T; Tsuchiya, N

Single Author

Exploring GSEA analysis on the biological role of FGFR4 Expression in Clear Cell Renal Cell Carcinoma, CANCER SCIENCE, 116 1471, 2025.01

Narisawa, T; Suenaga, S; Takai, Y; Takai, S; Ushijima, M; Yagi, M; Ito, H; Naito, S; Tsuchiya, N

Single Author

Investigation of the relationship between CTNNA1 and migration ability in clear cell renal cell carcinoma, CANCER SCIENCE, 116 1659, 2025.01

Suenaga, S; Narisawa, T; Horie, S; Takai, Y; Ushijima, M; Yagi, M; Ito, H; Naito, S; Tsuchiya, N

Single Author

GPI-80 and CRP as biomarkers predicting response to nivolumab-ipilimumab treatment in renal cancer, CANCER SCIENCE, 116 1473, 2025.01

Naito, S; Takeda, Y; Sabrina, S; Ito, H; Narisawa, T; Takai, Y; Suenaga, S; Yagi, M; Asao, H; Tsuchiya, N

Single Author

Stress-induced sympathetic stimulation inhibits ferroptosis through inactivation of p38 MAPK in renal cell carcinoma, CANCER SCIENCE, 116 1755, 2025.01

Ito, H; Ushijima, M; Naito, S; Ichiyanagi, O; Narisawa, T; Tsuchiya, N

Single Author

Dialysis Duration, Time Interaction, and Visceral Fat Accumulation: A 6-Year Posttransplantation Study, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 28(9) 943-952, 2024.09

Fukuhara, H; Nishida, H; Takai, S; Nawano, T; Takehara, T; Takai, Y; Narisawa, T; Kanno, H; Yagi, M; Yamagishi, A; Naito, S; Tsuchiya, N

Single Author

The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy, International Journal of Clinical Oncology, 29(7) 1019-1026, 2024.07

Numakura Kazuyuki, Sekine Yuya, Osawa Takahiro, Naito Sei, Tokairin Ojiro, Muto Yumina, Sobu Ryuta, Kobayashi Mizuki, Sasagawa Hajime, Yamamoto Ryohei, Nara Taketoshi, Saito Mitsuru, Narita Shintaro, ...

Single Author

Editorial Comment from Dr Naito to The significance of G8 and other geriatric assessments in urologic cancer management: A comprehensive review, INTERNATIONAL JOURNAL OF UROLOGY, 31(6) 615-616, 2024.06

Naito, S

Single Author

The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 29(7) 1019-1026, 2024.05

Numakura, K; Sekine, Y; Osawa, T; Naito, S; Tokairin, O; Muto, Y; Sobu, R; Kobayashi, M; Sasagawa, H; Yamamoto, R; Nara, T; Saito, M; Narita, S; Akashi, H; Tsuchiya, N; Shinohara, N; Habuchi, T

Single Author

Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan, INTERNATIONAL JOURNAL OF UROLOGY, 31(5) 552-559, 2024.05

Kita, Y; Otsuka, H; Ito, K; Hara, T; Shimura, S; Kawahara, T; Kato, M; Kanamaru, S; Inoue, K; Ito, H; Igarashi, A; Sazuka, T; Takamatsu, D; Hashimoto, K; Abe, T; Naito, S; Matsui, Y; Nishiyama, H; Kit...

Single Author

Ankrd1 promotes motility and invasion of renal cell carcinoma cells, CANCER SCIENCE, 115 973, 2024.03

Takai, Y; Naito, S; Ito, H; Horie, S; Ushijima, M; Narisawa, T; Yagi, M; Ichiyanagi, O; Tsuchiya, N

Single Author

BCL2A1 plays an important role in evading apoptosis in renal cell carcinoma, CANCER SCIENCE, 115 1319, 2024.03

Yagi, M; Naito, S; Ito, H; Takai, Y; Ushijima, M; Narisawa, T; Tsuchiya, N

Single Author

In vitro investigation of CD74 and CTNNA1 in clear cell renal cell carcinoma, CANCER SCIENCE, 115 1408, 2024.03

Narisawa, T; Suenaga, S; Horie, S; Takai, Y; Ushijima, M; Yagi, M; Ito, H; Naito, S; Tsuchiya, N

Single Author

Stress-induced sympathetic stimulation inhibits sorafenib-induced ferroptosis in renal cell carcinoma, CANCER SCIENCE, 115 679, 2024.03

Ito, H; Ushijima, M; Naito, S; Ichiyanagi, O; Narisawa, T; Tsuchiya, N

Single Author

Risk of postoperative recurrence and prediction of drug response in localized clear cell renal cell carcinoma, CANCER SCIENCE, 115 1409, 2024.03

Ichiyanagi, O; Naito, S; Ito, H; Narisawa, T; Yagi, M; Takai, Y; Kanno, H; Tsuchiya, N

Single Author

Metabolites of VEGFR/TKI and ICI responders in primary ccRCC specimens, CANCER SCIENCE, 115 1407, 2024.03

Naito, S; Ito, H; Narisawa, T; Horie, S; Suenaga, S; Takai, Y; Yagi, M; Tsuchiya, N

Single Author

Germline HLA-DQB1*03:01 is an independent prognostic factor for clinical outcomes in patients with urothelial cancer treated with pembrolizumab, EUROPEAN UROLOGY, 85 S1722-S1723, 2024.03

Narita, N; Takahashi, S; Fujiyama, NF; Hatakeyama, S; Kobayashi, TK; Kato, R; Naito, S; Sobu, R; Mori, K; Mori, M; Sekine, Y; Kobayashi, M; Numakura, K; Saito, M; Tsuchiya, N; Obara, W; Habuchi, T

Single Author

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database, CANCER MEDICINE, 12(22) 20677-20689, 2023.11

Koguchi, T; Naito, S; Hatakeyama, S; Numakura, K; Muto, Y; Kato, R; Kojima, T; Kawasaki, Y; Morozumi, K; Kandori, S; Kawamura, S; Nishiyama, H; Ito, A; Habuchi, T; Obara, W; Ohyama, C; Tsuchiya, N; Ko...

Single Author

Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by <i>Bacillus Calmette-Guérin</i>, BIOMEDICINES, 11(11) , 2023.11

Takeda, Y; Kato, T; Sabrina, S; Naito, S; Ito, H; Emi, N; Kuboki, Y; Takai, Y; Fukuhara, H; Ushijima, M; Narisawa, T; Yagi, M; Kanno, H; Sakurai, T; Nishida, H; Araki, A; Shimotai, Y; Nagashima, M; No...

Single Author

Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 28(11) 1538-1544, 2023.11

Horie, S; Naito, S; Hatakeyama, S; Kandori, S; Numakura, K; Kato, R; Koguchi, T; Myoen, S; Kawasaki, Y; Ito, A; Adachi, H; Kojima, Y; Obara, W; Habuchi, T; Nishiyama, H; Ohyama, C; Tsuchiya, N

Single Author

Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site, ANTICANCER RESEARCH, 43(11) 5041-5050, 2023.11

Nishiyama, N; Kita, Y; Ito, K; Kato, M; Hatakeyama, S; Matsushita, Y; Naito, S; Miyake, M; Nakanishi, S; Kato, Y; Shibuya, T; Hayashi, T; Yasumoto, H; Yoshida, T; Uemura, M; Taoka, R; Nishiyama, H; Ko...

Single Author

A durable complete response resulting from treatment with nivolumab plus ipilimumab for metastatic collecting duct carcinoma of the kidney, ASIAN JOURNAL OF UROLOGY, 10(3) 376-378, 2023.07

Funajima, K; Naito, S; Kabasawa, T; Nishida, H; Kato, T; Futakuchi, M; Tsuchiya, N

Single Author

Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study (vol 27, pg 563, 2022), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 28(5) 726-727, 2023.05

Kato, R; Naito, S; Numakura, K; Hatakeyama, S; Koguchi, T; Kojima, T; Kawasaki, Y; Kandori, S; Kawamura, S; Arai, Y; Ito, A; Nishiyama, H; Kojima, Y; Ohyama, C; Habuchi, T; Tsuchiya, N; Obara, W

Single Author

Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma, BIOMEDICINES, 11(5) , 2023.04

Kurota, Y; Takeda, Y; Ichiyanagi, O; Saitoh, S; Ito, H; Naito, S; Asao, H; Tsuchiya, N

Single Author

Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma, BIOMEDICINES, 11(5) , 2023.04

Sabrina, S; Takeda, Y; Kato, T; Naito, S; Ito, H; Takai, Y; Ushijima, M; Narisawa, T; Kanno, H; Sakurai, T; Saitoh, S; Araki, A; Tsuchiya, N; Asao, H

Single Author

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma, BMC CANCER, 23(1) , 2023.02

Narisawa, T; Naito, S; Ito, H; Ichiyanagi, O; Sakurai, T; Kato, T; Tsuchiya, N

Single Author

MDSCs function analysis as a prediction of therapeutic effect for patients with advanced renal cell carcinoma, CANCER SCIENCE, 114 1406, 2023.02

Sabrina, S; Kato, T; Takeda, Y; Naito, S; Ito, H; Takai, Y; Ushijima, M; Narisawa, T; Kanno, H; Sakurai, Y; Tsuchiya, N; Asao, H

Single Author

External validation of the GRANT score for postoperative survival prediction of non-metastatic RCC in open databases, CANCER SCIENCE, 114 1963, 2023.02

Ichiyanagi, O; Naito, S; Ito, H; Narisawa, T; Yagi, M; Kanno, H; Takai, Y; Sakurai, T; Tsuchiya, N

Single Author

Clinical impact of early response to first-line VEGFR-TKI in patients with metastatic renal cell carcinoma on survival: A multi-institutional retrospective study, CANCER MEDICINE, 12(4) 4100-4109, 2023.02

Sobu, R; Numakura, K; Naito, S; Hatakeyama, S; Kato, RP; Koguchi, T; Kojima, T; Kawasaki, Y; Kandori, S; Kawamura, S; Arai, Y; Ito, A; Nishiyama, H; Kojima, Y; Obara, W; Ohyama, C; Tsuchiya, N; Habuch...

Single Author

The roles of Ankrd1 in invasion and metastasis of renal cell carcinoma, CANCER SCIENCE, 114 1962, 2023.02

Takai, Y; Naito, S; Ito, H; Takai, S; Narisawa, T; Kanno, H; Yagi, M; Sakurai, T; Tsuchiya, N

Single Author

Metabolic classification of clear cell renal cell carcinoma and search for therapeutic target metabolites, CANCER SCIENCE, 114 2167, 2023.02

Naito, S; Ito, H; Makinoshima, H; Tsuchiya, N

Single Author

β2 Adrenergic Receptor Stimulation Is Involved in Multikinase Inhibitor Resistance in Renal Cell Carcinoma, CANCER SCIENCE, 114 2170, 2023.02

Ushijima, M; Naito, S; Ito, H; Narisawa, T; Horie, S; Takai, Y; Ozawa, M; Yagi, M; Kanno, H; Sakurai, T; Tsuchiya, N

Single Author

Long term anti-vascular endothelial growth factor receptor treatment impairs renal function in renal cell carcinoma, EUROPEAN UROLOGY, 83 S486, 2023.02

Naito, S; Otake, K; Tsuchiya, N

Single Author

Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma, ASIAN JOURNAL OF UROLOGY, 10(1) 103-105, 2023.01

Kurokawa, M; Naito, S; Kato, T; Ushijima, M; Yamagishi, A; Sakurai, T; Nishida, H; Tsuchiya, N

Single Author

Anti-human leukocyte antigen and anti-ABO antibodies after SARS-CoV-2 mRNA vaccination in kidney transplant recipients, CLINICAL TRANSPLANTATION, 37(5) , 2023

Nishida, H; Takai, S; Ito, H; Fukuhara, H; Nawano, T; Narisawa, T; Kanno, H; Yagi, M; Yamagishi, A; Sakurai, T; Naito, S; Tsuchiya, N

Single Author

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab, CANCER SCIENCE, 113(12) 4059-4069, 2022.12

Takahashi, S; Narita, S; Fujiyama, N; Hatakeyama, S; Kobayashi, T; Kato, R; Naito, S; Sakatani, T; Kashima, S; Koizumi, A; Yamamoto, R; Nara, T; Kanda, S; Numakura, K; Saito, M; Obara, W; Tsuchiya, N;...

Single Author

ペムブロリズマブの治療を受けた尿路上皮癌患者における生殖細胞系列HLA遺伝子型の臨床転帰への影響(Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab), Cancer Science, 113(12) 4059-4069, 2022.12

Takahashi Shuhei, Narita Shintaro, Fujiyama Nobuhiro, Hatakeyama Shingo, Kobayashi Takashi, Kato Renpei, Naito Sei, Sakatani Toru, Kashima Soki, Koizumi Atsushi, Yamamoto Ryohei, Nara Taketoshi, Kanda...

Single Author

Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients, FRONTIERS IN IMMUNOLOGY, 13 , 2022.11

Takai, S; Nishida, H; Ito, H; Fukuhara, H; Nawano, T; Narisawa, T; Kanno, H; Yagi, M; Yamagishi, A; Sakurai, T; Naito, S; Kato, T; Morikane, K; Tsuchiya, N

Single Author

Immunogenicity and safety of two doses of SARS-CoV-2 mRNA vaccine in kidney transplant recipients with low-dose rituximab, INTERNATIONAL JOURNAL OF UROLOGY, 29(11) 1279-1286, 2022.11

Takai, S; Nishida, H; Ito, H; Fukuhara, H; Nawano, T; Narisawa, T; Kanno, H; Yagi, M; Yamagishi, A; Sakurai, T; Naito, S; Kato, T; Morikane, K; Tsuchiya, N

Single Author

Body composition changes following chemotherapy for testicular germ cell tumor: obesity is the long-term problem, ASIAN JOURNAL OF ANDROLOGY, 24(5) 458-+, 2022.09

Takai, Y; Naito, S; Kanno, H; Yamagishi, A; Yagi, M; Sakurai, T; Nishida, H; Yamanobe, T; Kato, T; Tsuchiya, N

Single Author

Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis, BJU INTERNATIONAL, 130(2) 226-234, 2022.08

Kobayashi, M; Narita, S; Matsui, Y; Kanda, S; Hidaka, Y; Abe, H; Tsuzuki, T; Ito, K; Kojima, T; Kato, M; Hatakeyama, S; Matsushita, Y; Naito, S; Shiga, M; Miyake, M; Muro, Y; Nakanishi, S; Kato, Y; Sh...

Single Author

Effect of Extracellular Signal-Regulated Protein Kinase 5 Inhibition in Clear Cell Renal Cell Carcinoma, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23(15) , 2022.08

Kanno, H; Naito, S; Obara, Y; Ito, H; Ichiyanagi, O; Narisawa, T; Kato, T; Nagaoka, A; Tsuchiya, N

Single Author

Exploratory analysis on crosstalk between intra-tumor immunity and FGF/FGFR pathway in clear cell renal cell carcinoma., JOURNAL OF CLINICAL ONCOLOGY, 40(16) E16525, 2022.06

Narisawa, T; Naito, S; Mitsuda, Y; Oe, R; Sato, H; Kobayashi, C; Fukuda, M; Kitaoka, T; Miyano, Y; Ito, H; Kimura, M; Hamaguchi, M; Aoshima, K; Futakuchi, M; Tsuchiya, N

Single Author

Surgical and focal treatment for metastatic renal cell carcinoma: A literature review, INTERNATIONAL JOURNAL OF UROLOGY, 29(6) 494-501, 2022.06

Naito, S; Kato, T; Tsuchiya, N

Single Author

Outcomes of Living Kidney Transplantation for Mitochondrial Disease Patients: A Case Series, TRANSPLANTATION PROCEEDINGS, 54(2) 267-271, 2022.03

Nishida, H; Nawano, T; Fukuhara, H; Takai, S; Narisawa, T; Kanno, H; Yagi, M; Yamagishi, A; Sakurai, T; Naito, S; Kato, T; Tsuchiya, N

Single Author

Changes in Visceral and Subcutaneous Adipose Tissue and Body Composition in Kidney Transplant Recipients at 1, 3, and 5 Years After Kidney Transplant, TRANSPLANTATION PROCEEDINGS, 54(2) 351-354, 2022.03

Fukuhara, H; Nishida, H; Nawano, T; Takai, S; Narisawa, T; Kanno, H; Yagi, M; Yamagishi, A; Sakurai, T; Naito, S; Kato, T; Tsuchiya, N

Single Author

Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 27(3) 563-573, 2022.03

Kato, R; Naito, S; Numakura, K; Hatakeyama, S; Koguchi, T; Kojima, T; Kawasaki, Y; Kandori, S; Kawamura, S; Arai, Y; Ito, A; Nishiyama, H; Kojima, Y; Ohyama, C; Habuchi, T; Tsuchiya, N; Obara, W

Single Author

Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 40(3) , 2022.03

Taoka, R; Kobayashi, T; Hidaka, Y; Abe, H; Ito, K; Kojima, T; Kato, M; Kanda, S; Hatakeyama, S; Matsui, Y; Matsushita, Y; Naito, S; Shiga, M; Miyake, M; Muro, Y; Nakanishi, S; Kato, Y; Shibuya, T; Hay...

Single Author

IMDCリスクで層別化した、標的治療時代における転移性腎細胞癌へのupfront cytoreductive nephrectomyの意義　多施設共同後ろ向き研究(Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era: a multi-institutional retrospective study), International Journal of Clinical Oncology, 27(3) 563-573, 2022.03

Kato Renpei, Naito Sei, Numakura Kazuyuki, Hatakeyama Shingo, Koguchi Tomoyuki, Kojima Takahiro, Kawasaki Yoshihide, Kandori Shuya, Kawamura Sadafumi, Arai Yoichi, Ito Akihiro, Nishiyama Hiroyuki, Koj...

Single Author

Heterogeneity of neutrophils in renal cell and urothelial carcinoma patients during immune checkpoint inhibition therapy, CANCER SCIENCE, 113 514, 2022.02

Saima, S; Kato, T; Takeda, Y; Naito, S; Ito, H; Takai, Y; Ushijima, M; Ozawa, M; Narisawa, T; Kanno, H; Sakurai, T; Tsuchiya, N; Asao, H

Single Author

Increase in <i>MKNK2</i> expression with 4EBP1/eIF4E hyperactivation may predict late recurrence of localized clear cell RCC, CANCER SCIENCE, 113 1585, 2022.02

Ichiyanagi, O; Naito, S; Narisawa, T; Yagi, M; Kanno, H; Ushijima, M; Takai, Y; Sakurai, T; Ito, H; Kato, T; Tsuchiya, N

Single Author

Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma (vol 51, pg 1656, 2021), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(12) 1770, 2021.12

Tomita, Y; Kimura, G; Fukasawa, S; Numakura, K; Sugiyama, Y; Yamana, K; Naito, S; Kaneko, H; Tajima, Y; Oya, M

Single Author

Adjuvant heparinization before manipulation of artery reduces early failure in primary arteriovenous fistula for end-stage renal disease patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 25(12) 1346-1353, 2021.12

Nishida, H; Fukuhara, H; Nawano, T; Kanno, H; Yagi, M; Yamagishi, A; Sakurai, T; Naito, S; Kato, T; Kudo, K; Ichikawa, K; Tsuchiya, N

Single Author

External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study, UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 39(12) , 2021.12

Okita, K; Hatakeyama, S; Naito, S; Numakura, K; Kato, R; Koguchi, T; Kojima, T; Kawasaki, Y; Kandori, S; Kawamura, S; Nishiyama, H; Ito, A; Kojima, Y; Habuchi, T; Obara, W; Tsuchiya, N; Ohyama, C

Single Author

Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(11) 1656-1664, 2021.11

Tomita, Y; Kimura, G; Fukasawa, S; Numakura, K; Sugiyama, Y; Yamana, K; Naito, S; Kaneko, H; Tajima, Y; Oya, M

Single Author

AFTER I-O試験のサブグループ解析　日本人転移性腎細胞癌患者における癌免疫療法後の分子標的治療の有効性と安全性に関する後方視的研究(Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma), Japanese Journal of Clinical Oncology, 51(11) 1656-1664, 2021.11

Tomita Yoshihiko, Kimura Go, Fukasawa Satoshi, Numakura Kazuyuki, Sugiyama Yutaka, Yamana Kazutoshi, Naito Sei, Kaneko Hirokazu, Tajima Yohei, Oya Mototsugu

Single Author

Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 26(10) 1947-1954, 2021.10

Naito, S; Kato, T; Numakura, K; Hatakeyama, S; Koguchi, T; Kandori, S; Kawasaki, Y; Adachi, H; Kato, R; Narita, S; Yamamoto, H; Ogawa, S; Kawamura, S; Obara, W; Ito, A; Nishiyama, H; Kojima, Y; Ohyama...

Single Author

IMPACT OF GERMLINE HLA STATUS ON CLINICAL OUTCOMES IN PATIENTS WITH CHEMORESISTANT UROTHELIAL CANCER TREATED WITH PEMBROLIZUMAB, JOURNAL OF UROLOGY, 206 E1001, 2021.09

Narita, S; Fujiyama, N; Takahashi, S; Kobayashi, T; Hatakeyama, S; Naito, S; Kato, R; Sakatani, T; Kashima, S; Yamamoto, R; Koizumi, A; Nara, T; Numakura, K; Saito, M; Habuchi, T

Single Author

VALIDATION OF REMARCC MODEL FOR SELECTION OF CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH MRCC, JOURNAL OF UROLOGY, 206 E259-E260, 2021.09

Hatakeyama, S; Naito, S; Numakura, K; Kato, R; Koguchi, T; Kojima, T; Kawasaki, Y; Kawamura, S; Hiroyuki, N; Ito, A; Kojima, Y; Habuch, T; Obara, W; Tsuchiya, N; Ohyama, C

Single Author

Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology era, CANCER MEDICINE, 10(17) 5839-5846, 2021.09

Numakura, K; Muto, Y; Naito, S; Hatakeyama, S; Kato, R; Koguchi, T; Kojima, T; Kawasaki, Y; Kandori, S; Kawamura, S; Arai, Y; Ito, A; Nishiyama, H; Kojima, Y; Obara, W; Ohyama, C; Tsuchiya, N; Habuchi...

Single Author

Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(6) 966-975, 2021.06

Tomita, Y; Kimura, G; Fukasawa, S; Numakura, K; Sugiyama, Y; Yamana, K; Naito, S; Kabu, K; Tajima, Y; Oya, M

Single Author

Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma, INTERNATIONAL JOURNAL OF UROLOGY, 28(4) 450-456, 2021.04

Naito, S; Narisawa, T; Kato, T; Ichiyanagi, O; Kurokawa, M; Yagi, M; Kanno, H; Kurota, Y; Yamagishi, A; Sakurai, T; Nishida, H; Yamanobe, T; Tsuchiya, N

Single Author

Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study, INTERNATIONAL JOURNAL OF UROLOGY, 28(4) 369-375, 2021.04

Hatakeyama, S; Naito, S; Numakura, K; Kato, R; Koguchi, T; Kojima, T; Kawasaki, Y; Kandori, S; Kawamura, S; Tsushima, E; Nishiyama, H; Ito, A; Kojima, Y; Habuchi, T; Obara, W; Tsuchiya, N; Ohyama, C

Single Author

The comparison of cytoreductive nephrectomy (CN) with tyrosine kinase inhibitor therapy alone in patients with primary metastatic renal cell carcinoma (mRCC)., JOURNAL OF CLINICAL ONCOLOGY, 39(6) , 2021.02

Hatakeyama, S; Naito, S; Numakura, K; Kato, R; Koguchi, T; Kojima, T; Kawasaki, Y; Kandori, K; Tsushima, E; Nishiyama, H; Ito, A; Kojima, Y; Habuchi, T; Obara, W; Tsuchiya, N; Ohyama, C

Single Author

Analysis of inflammatory response during intravesical immunotherapy with BCG for non-muscle invasive bladder cancer, CANCER SCIENCE, 112 841, 2021.02

Takeda, Y; Kato, T; Naito, S; Ito, H; Ushijima, M; Narisawa, T; Kanno, H; Kurota, Y; Tsuchiya, N; Asao, H

Single Author

predictive biomarkers for treatment selection of sorafenib or sunitinib in metastatic renal cell carcinoma., CANCER SCIENCE, 112 509, 2021.02

Naito, S; Bilim, V; Tsuchiya, N; Tomita, Y

Single Author

Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab, CANCER SCIENCE, 112(2) 760-773, 2021.02

Kobayashi, T; Ito, K; Kojima, T; Kato, M; Kanda, S; Hatakeyama, S; Matsui, Y; Matsushita, Y; Naito, S; Shiga, M; Miyake, M; Muro, Y; Nakanishi, S; Kato, Y; Shibuya, T; Hayashi, T; Yasumoto, H; Yoshida...

Single Author

Post-operative prediction of late recurrence of localized clear cell RCC using clinical models already reported, CANCER SCIENCE, 112 835, 2021.02

Ichiyanagi, O; Naito, S; Narisawa, T; Yagi, M; Kanno, H; Sakurai, T; Ito, H; Kato, T; Tsuchiya, N

Single Author

Dynamic changes in myeloid cells in urological cancer patients during immune checkpoint treatment, CANCER SCIENCE, 112 837, 2021.02

Kato, T; Takeda, Y; Naito, S; Ito, H; Ushijima, M; Narisawa, T; Yagi, M; Kanno, H; Sakurai, T; Yamanobe, T; Asao, H; Tsuchiya, N

Single Author

Sports Camera Calibration using Flexible Intersection Selection and Refinement, ITE TRANSACTIONS ON MEDIA TECHNOLOGY AND APPLICATIONS, 9(1) 95-104, 2021

Tsurusaki, H; Nonaka, K; Watanabe, R; Konno, T; Naito, S

Single Author

Aggregating Everyday Outfits by Incremental Clustering With Interactive User Adaptation, IEEE ACCESS, 9 121467-121475, 2021

Kawanishi, Y; Murase, H; Komorita, S; Naito, S

Single Author

Effect of general self-efficacy on promoting health-related quality of life during recovery from radical prostatectomy: a 1-year prospective study, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25(12) 2122-2129, 2020.12

Kawaguchi, K; Kawazoe, H; Sakurai, T; Nishida, H; Kanno, H; Naito, S; Kato, T; Konta, T; Tsuchiya, N; Sato, W

Single Author

Association between Hyposensitivity of C-fiber Afferents at The Proximal Urethra and Storage/voiding Dysfunction in Female Patients with Detrusor Overactivity, UROLOGY JOURNAL, 17(6) 631-637, 2020.11

Ichiyanagi, O; Nishimoto, K; Nagaoka, A; Naito, S; Yagi, M; Ushijima, M; Kato, T; Tsuchiya, N

Single Author

Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus., IJU case reports, 3(5) 181-183, 2020.09

Kurokawa M, Naito S, Ito S, Takai S, Kawamura Y, Kaneko H, Kakizaki H, Tsuchiya N

Single Author

Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC, CLINICAL GENITOURINARY CANCER, 18(4) E374-E385, 2020.08

Tomita, Y; Naito, S; Sassa, N; Takahashi, A; Kondo, T; Koie, T; Obara, W; Kobayashi, Y; Teishima, J; Takahashi, M; Matsuyama, H; Ueda, T; Yamaguchi, K; Kishida, T; Shiroki, R; Saika, T; Shinohara, N; ...

Single Author

Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25(8) 1543-1550, 2020.08

Numakura, K; Kobayashi, M; Hatakeyama, S; Naito, S; Horikawa, Y; Tanaka, T; Kamada, S; Muto, Y; Yamamoto, R; Koizumi, A; Nara, T; Kanda, S; Saito, M; Narita, S; Inoue, T; Shimoda, N; Tsuchiya, N; Ohya...

Single Author

Living kidney transplantation without perioperative anticoagulation therapy for a patient with heparin-induced thrombocytopenia., IJU case reports, 3(3) 86-89, 2020.05

Nishida H, Fukuhara H, Yamagishi A, Hosoya N, Ichiyanagi O, Sakurai T, Naito S, Yamanobe T, Kato T, Tsuchiya N

Single Author

New prognostic model for synchronous metastatic renal cell carcinoma, INTERNATIONAL JOURNAL OF UROLOGY, 27(5) 448-456, 2020.05

Naito, S; Kato, T; Ichiyanagi, O; Narisawa, T; Kurokawa, M; Yagi, M; Ushijima, M; Ozawa, M; Kanno, H; Kurota, Y; Fukuhara, H; Kuboki, Y; Yamagishi, A; Sakurai, T; Nishida, H; Yamanobe, T; Tsuchiya, N

Single Author

Treatment-free survival after discontinuation of immuno-checkpoint therapy, and outcome of subsequent molecular targeted therapy: Retrospective study of Japanese metastatic renal cell carcinoma patients (after I-O study), JOURNAL OF CLINICAL ONCOLOGY, 38(6) , 2020.02

Tomita, Y; Kimura, G; Fukasawa, S; Sugiyama, Y; Numakura, K; Yamana, K; Naito, S; Kabu, K; Tajima, Y; Oya, M

Single Author

Primary mesenchymal chondrosarcoma of the kidney without <i>HEY1</i>-<i>NCOA2</i> and <i>IRF2BP2</i>-<i>CDX1</i> fusion: A case report and review, ONCOLOGY LETTERS, 19(1) 885-891, 2020.01

Yamagishi, A; Ichiyanagi, O; Naito, S; Ito, H; Kabasawa, T; Yamakawa, M; Tsuchiya, N

Single Author

Fast calculation method for viewpoint movements in computer-generated holograms using a Fourier transform optical system, APPLIED OPTICS, 58(34) G71-G83, 2019.12

Watanabe, R; Nakamura, T; Mitobe, M; Sakamoto, Y; Naito, S

Single Author

GPI-80 as a Useful Index for Myeloid Cell Heterogeneity and a Potential Prognostic Biomarker for Metastatic Renal Cell Carcinoma, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 249(3) 203-212, 2019.11

Kato, T; Takeda, Y; Ito, H; Kurota, Y; Yamagishi, A; Sakurai, T; Naito, S; Araki, A; Nara, H; Asao, H; Tsuchiya, N

Single Author

Synchronized Tracking in Multiple Omnidirectional Cameras with Overlapping View, IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS, E102D(11) 2221-2229, 2019.11

Sabirin, H; Nisheviura, H; Naito, S

Single Author

Effect of third- and fourth-line systemic therapies for metastatic renal cell carcinoma, SCIENTIFIC REPORTS, 9 , 2019.10

Naito, S; Ichiyanagi, O; Kato, T; Kanno, H; Narisawa, T; Kurokawa, M; Ushijima, M; Ozawa, M; Yagi, M; Kurota, Y; Fukuhara, H; Yamagishi, A; Sakurai, T; Nishida, H; Kawazoe, H; Yamanobe, T; Tsuchiya, N

Single Author

FGFR阻害剤とmTOR阻害剤併用試験からみるFGFR4の重要性(Importance of FGFR4 from the combined test of FGFR inhibitor and mTOR inhibitor in vitro evaluation), 日本癌学会総会記事, 78回 P-2139, 2019.09

成澤 貴史, 内藤 整, 伊藤 裕美, 小澤 迪喜, 牛島 正毅, 八木 真由, 菅野 秀典, 黒田 悠太, 櫻井 俊彦, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦

Single Author

EIF4E PHOSPHORYLATION INHIBITS METASTASIS IN CLEAR CELL RENAL CELL CARCINOMA, JOURNAL OF UROLOGY, 201(4) E209-E210, 2019.04

Naito Sei, Ichiyanagi Osamu, Hiromi Ito, Ozawa Michinobu, Ushijima Masaki, Yagi Mayu, Narisawa Takafumi, Kanno Hidenori, Kurota Yuta, Kato Tomoyuki, Tsuchiya Norihiko

Single Author

ROLE OF FGFR4 IN CLEAR CELL RENAL CARCINOMA AND ITS POTENTIAL AS A NEW THERAPEUTIC TARGET, JOURNAL OF UROLOGY, 201(4) E204-E205, 2019.04

Narisawa Takafumi, Naito Sei, Ito Hiromi, Sakurai Toshihiko, Ichiyanagi Osamu, Kato Tomoyuki, Makhov Peter, Kolenco Vladimir, Tsuchiya Norihiko

Single Author

Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinoma, ONCOLOGY LETTERS, 17(4) 3910-3918, 2019.04

Naito, S; Ichiyanagi, O; Ito, H; Kabasawa, T; Kanno, H; Narisawa, T; Fukuhara, H; Yagi, M; Kurota, Y; Yamagishi, A; Sakurai, T; Nishida, H; Kawazoe, H; Yamanobe, T; Kato, T; Makhov, P; Kolenko, VM; Ya...

Single Author

Possible role of hyposensitivity of C-fiber afferents at the proximal urethra in the development of urge urinary incontinence in patients with detrusor overactivity, LUTS-LOWER URINARY TRACT SYMPTOMS, 11(2) O21-O27, 2019.04

Ichiyanagi, O; Nagaoka, A; Naito, S; Tsukigi, M; Yagi, M; Kato, T; Ishigooka, M; Tsuchiya, N

Single Author

EIF4E PHOSPHORYLATION INHIBITS METASTASIS IN CLEAR CELL RENAL CELL CARCINOMA, JOURNAL OF UROLOGY, 201(4) E209-E210, 2019.04

Naito, S; Ichiyanagi, O; Hiromi, I; Ozawa, M; Ushijima, M; Yagi, M; Narisawa, T; Kanno, H; Kurota, Y; Kato, T; Tsuchiya, N

Single Author

EXTERNAL VALIDATION OF CHOKAI SCORE AND COMPARISON WITH STONE SCORE FOR THE PREDICTION OF URETERAL STONES IN JAPAN: A MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY, JOURNAL OF UROLOGY, 201(4) E222-E223, 2019.04

Fukuhara, H; Takai, S; Kikuta, M; Yamagishi, A; Suenaga, S; Sakurai, T; Naito, S; Nishida, H; Yamanobe, T; Kato, T; Tsuchiya, N

Single Author

ROLE OF FGFR4 IN CLEAR CELL RENAL CARCINOMA AND ITS POTENTIAL AS A NEW THERAPEUTIC TARGET, JOURNAL OF UROLOGY, 201(4) E204-E205, 2019.04

Narisawa, T; Naito, S; Ito, H; Sakurai, T; Ichiyanagi, O; Kato, T; Makhov, P; Kolenco, V; Tsuchiya, N

Single Author

The prognostic value of glycosylphosphatidylinositol-anchored 80 kD protein (GPI-80) positive myeloid derived suppressor cells (MDSCs) in peripheral blood of metastatic renal cell carcinoma (mRCC) patients., JOURNAL OF CLINICAL ONCOLOGY, 37(7) , 2019.03

Kato, T; Takeda, Y; Kurota, Y; Naito, S; Ito, H; Araki, A; Asao, H; Tsuchiya, N

Single Author

Reinforcement of the Triple D score with simple addition of the intrarenal location for the prediction of the stone-free rate after shockwave lithotripsy for renal stones 10-20mm in diameter, INTERNATIONAL UROLOGY AND NEPHROLOGY, 51(2) 239-245, 2019.02

Ichiyanagi, O; Fukuhara, H; Kurokawa, M; Izumi, T; Suzuki, H; Naito, S; Nishida, H; Kato, T; Tsuchiya, N

Single Author

Variation of gene expression profiling caused by adding LDL in renal cell carcinoma cell lines, CANCER SCIENCE, 109 981, 2018.12

Yagi, M; Naito, S; Ito, H; Narisawa, T; Kurota, Y; Kanno, H; Ushijima, M; Ozawa, M; Kato, T; Tsuchiya, N

Single Author

Ankrd1 as a potential therapeutic target for rapamycin-resistant renal cell carcinoma, CANCER SCIENCE, 109 984, 2018.12

Ozawa, M; Naito, S; Ito, H; Ushijima, M; Narisawa, T; Kanno, H; Kurota, Y; Yagi, M; Kato, T; Tsuchiya, N

Single Author

Clinical significance of GPI-80 expression in peripheral blood of metastatic renal cell cancer patients, CANCER SCIENCE, 109 993, 2018.12

Kato, T; Takeda, Y; Kurota, Y; Ito, H; Narisawa, T; Kanno, H; Yagi, M; Sakurai, T; Naito, S; Kawazoe, H; Yamanobe, T; Asao, H; Tsuchiya, N

Single Author

Role of FGFR4 in clear cell renal carinoma and its potential as a new drug target, CANCER SCIENCE, 109 987, 2018.12

Narisawa, T; Naito, S; Ito, H; Sakurai, T; Ozawa, M; Ushijima, M; Kanno, H; Yagi, M; Kurota, Y; Ichiyanagi, O; Kato, T; Tsuchiya, N

Single Author

Activation level of the mTORC1/4EBP1/eIF4E pathway is a predictor for recurrence of clear cell renal cell carcinoma, CANCER SCIENCE, 109 985, 2018.12

Ichiyanagi, O; Ito, H; Naito, S; Narisawa, T; Kurota, Y; Kanno, H; Yagi, M; Sakurai, T; Kawazoe, H; Yamanobe, T; Kato, T; Tsuchiya, N

Single Author

The role of beta-adrenoceptor and catecholamine stimuli in renal cell carcinoma, CANCER SCIENCE, 109 1279, 2018.12

Ushijima, M; Ichiyanagi, O; Ito, H; Naito, S; Narisawa, T; Yagi, M; Kurota, Y; Kanno, H; Sakurai, T; Kawazoe, H; Yamanobe, T; Kato, T; Tsuchiya, N

Single Author

Phospho-eIF4E prevents tumor recurrence by suppressing epithelial-mesenchymal transition in renal cell carcinoma, CANCER SCIENCE, 109 994, 2018.12

Ito, H; Ichiyanagi, O; Naito, S; Kanno, H; Narisawa, T; Kurota, Y; Kaneko, S; Ushijima, M; Ozawa, M; Yagi, M; Kato, T; Tsuchiya, N

Single Author

Patients with nuclear expression of ERK5 had poor prognosis in renal cell carcionoma, CANCER SCIENCE, 109 572, 2018.12

Naito, S; Kanno, H; Ito, H; Kato, T; Ichiyanagi, O; Narisawa, T; Supsup, MY; Ushijima, M; Ozawa, M; Kurota, Y; Sakurai, T; Tsuchiya, N

Single Author

GSK-3 can affect mRNA translation and proliferation via regulation of 4EBP1/eIF4E and MNK1/eIF4E in renal cell carcinoma, CANCER SCIENCE, 109 994, 2018.12

Kaneko, S; Ito, H; Naito, S; Narisawa, T; Kurota, Y; Kanno, H; Yagi, M; Ushijima, M; Ozawa, M; Ichiyanagi, O; Kato, T; Tsuchiya, N

Single Author

Levels of 4EBP1/eIF4E Activation in Renal Cell Carcinoma Could Differentially Predict Its Early and Late Recurrence, CLINICAL GENITOURINARY CANCER, 16(5) E1029-E1058, 2018.10

Ichiyanagi, O; Naito, S; Ito, H; Kabasawa, T; Narisawa, T; Kanno, H; Kurota, Y; Kurokawa, M; Fukuhara, H; Sakurai, T; Nishida, H; Kato, T; Yamakawa, M; Tsuchiya, N

Single Author

Optimal Billboard Deformation via 3D Voxel for Free-Viewpoint System, IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS, E101D(9) 2381-2391, 2018.09

Nonaka, K; Sabirin, H; Chen, J; Sankoh, H; Naito, S

Single Author

ERK5 IS A PROMISING THERAPEUTIC TARGET FOR CLEAR CELL RENAL CELL CARCINOMA, JOURNAL OF UROLOGY, 199(4) E1204, 2018.04

Kanno, H; Naito, S; Ichiyanagi, O; Narisawa, T; Ito, H; Nagaoka, A; Ito, S; Suenaga, S; Fukuhara, H; Kurota, Y; Yagi, M; Yamagishi, A; Sakurai, T; Nishida, H; Kawazoe, H; Abe, A; Yamanobe, T; Kato, T;...

Single Author

Toward Real-Time Delivery of Immersive Sports Content, IEEE MULTIMEDIA, 25(2) 61-70, 2018.04

Sabirin, H; Yao, Q; Nonaka, K; Sankoh, H; Naito, S

Single Author

The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma, CELL DEATH & DISEASE, 9 , 2018.03

Makhov, P; Naito, S; Haifler, M; Kutikov, A; Boumber, Y; Uzzo, RG; Kolenko, VM

Single Author

GPI-80, a useful marker of MDSC in mRCC patients, is a reference for the search for new MDSC markers, CANCER SCIENCE, 109 332, 2018.01

Kato, T; Takeda, Y; Ito, H; Kurota, Y; Yagi, M; Sakurai, T; Naito, S; Kawazoe, H; Ichiyanagi, O; Tsuchiya, N; Asao, H

Single Author

In vitro investigation of significance of fibroblast growth factor receptor type 4 (FGFR4) in RCC cell lines, CANCER SCIENCE, 109 329, 2018.01

Narisawa, T; Sakurai, T; Naito, S; Ito, H; Kanno, H; Ichiyanagi, O; Kato, T; Tsuchiya, N

Single Author

The Effects of ERK5 Inhibition in Clear Cell Renal Cell Carcinoma, CANCER SCIENCE, 109 614, 2018.01

Kanno, H; Ito, H; Yagi, M; Sakurai, T; Naito, S; Kawazoe, H; Ichiyanagi, O; Kato, T; Tsuchiya, N

Single Author

Gene expressions in rapamycin resistant RCC cell line, CANCER SCIENCE, 109 1147, 2018.01

Naito, S; Ito, H; Ichiyanagi, O; Kanno, H; Narisawa, T; Yagi, M; Kurota, Y; Kawazoe, H; Kato, T; Tsuchiya, N

Single Author

Efficient Parallel Connected Component Labeling With a Coarse-to-Fine Strategy, IEEE ACCESS, 6 55731-55740, 2018

Chen, J; Nonaka, K; Sankoh, H; Watanabe, R; Sabirin, H; Naito, S

Single Author

Renopreotective Procedures with a Cold Ischemia Time of <60 min Minimize the Deterioration of Kidney Function in Open Nephron-Sparing Surgery for Renal Cell Carcinoma., Urologia internationalis, 2017.10

Nishida H, Yamagishi A, Yagi M, Kanno H, Kurota Y, Sakurai T, Naito S, Shibasaki T, Kawazoe H, Ichiyanagi O, Kato T, Nagaoka A, Tomita Y, Tsuchiya N.

Multiple Authorship (Only Japanese)

Testing PARP inhibitors using a murine xenograft model. , Methods in molecular biology, 2017.07

Makhov P, Naito S, Kolenko VM.

Multiple Authorship (Including Foreigners)

Acquisition of chemoresistance to mTORC1 inhibition due to activation of the GSK-3β/4EBP1 pathway might predict poor prognosis of mRCC patients, CANCER RESEARCH, 77 , 2017.07

Ito, H; Naito, S; Ichiyanagi, O; Kanno, H; Kurota, Y; Yamagishi, A; Bilim, V; Tomita, Y; Kato, T; Nagaoka, A; Tsuchiya, N

Single Author

The potential of p4EBP1 expression as predictive biomarker of mRCC, CANCER RESEARCH, 77 , 2017.07

Naito, S; Ichiyanagi, O; Ito, H; Kanno, H; Kato, T; Kurota, Y; Yamagishi, A; Yagi, M; Sakurai, T; Nishida, H; Kawazoe, H; Shibasaki, T; Nagaoka, A; Tsuchiya, N

Single Author

The effect of ERK5 inhibition in clear cell renal cell carcinoma, CANCER RESEARCH, 77 , 2017.07

Kanno, H; Naito, S; Ichiyanagi, O; Tsuchiya, N

Single Author

LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma. , British journal of Cancer, 2017.04

Naito S, Makhov P, Astsaturov I, Golovine K, Ulin A, utikov A, Uzzo RG, Kolenko VM.

Multiple Authorship (Only Japanese)

Rise in ambient temperature predisposes aging, male Japanese patients to renal colic episodes due to upper urolithiasis, SCANDINAVIAN JOURNAL OF UROLOGY, 51(2) 152-158, 2017.04

Ichiyanagi, O; Fukuhara, H; Naito, S; Nishida, H; Sakurai, T; Kurokawa, M; Ito, H; Kakizaki, H; Muto, A; Adachi, Y; Kato, T; Nagaoka, A; Tsuchiya, N

Single Author

LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma, BRITISH JOURNAL OF CANCER, 116(9) 1203-1207, 2017.04

Naito, S; Makhov, P; Astsaturov, I; Golovine, K; Tulin, A; Kutikov, A; Uzzo, RG; Kolenko, VM

Single Author

Sunitinib versus sorafenib as first-line therapy followed by sorefenib and sunitinib for patients with metastatic renal cell carcinoma (RCC) with clear cell histology: A multicenter randomized trial, CROSS-J-RCC., JOURNAL OF CLINICAL ONCOLOGY, 35(6) , 2017.02

Tomita, Y; Naito, S; Sassa, N; Takahashi, A; Kondo, T; Koie, T

Single Author

Rise in ambient temperature predisposes aging, male Japanese patients to renal colic episodes due to upper urolithiasis., Scandinavian journal of Urology, 2017.01

Ichiyanagi O, Fukuhara H, Naito S, Nishida H, Sakurai T, Kurokawa M, Ito H, Kakizaki H, Muto A, Adachi Y, Kato T, Nagaoka A, Tsuchiya N.

Multiple Authorship (Only Japanese)

Renoprotective Procedures with a Cold Ischemia Time of &lt;60 min Minimize the Deterioration of Kidney Function in Open Nephron-Sparing Surgery for Renal Cell Carcinoma, UROLOGIA INTERNATIONALIS, 99(3) 283-289, 2017

Nishida, H; Yamagishi, A; Yagi, M; Kanno, H; Kurota, Y; Sakurai, T; Naito, S; Shibasaki, T; Kawazoe, H; Ichiyanagi, O; Kato, T; Nagaoka, A; Tomita, Y; Tsuchiya, N

Single Author

Expression of Extracellular Signal-regulated Kinase 5 and Ankyrin Repeat Domain 1 in Composite Pheochromocytoma and Ganglioneuroblastoma Detected Incidentally in the Adult Adrenal Gland., Internal Medicine, 2016.12

Suenaga S, Ichiyanagi O, Ito H, Naito S, Kato T, Nagaoka A, Kato T, Yamakawa M, Obara Y, Tsuchiya N.

Multiple Authorship (Only Japanese)

Clinical relevance of seasonal changes in the prevalence of ureterolithiasis in the diagnosis of renal colic., Urolithiasis, 2016.11

Fukuhara H, Ichiyanagi O, Kakizaki H, Naito S, Tsuchiya N.

Multiple Authorship (Only Japanese)

Clinical relevance of seasonal changes in the prevalence of ureterolithiasis in the diagnosis of renal colic, UROLITHIASIS, 44(6) 529-537, 2016.11

Fukuhara, H; Ichiyanagi, O; Kakizaki, H; Naito, S; Tsuchiya, N

Single Author

GSK-3 can directly phosphorylate 4EBP1 in a distinct pathway from AKT/mTORC1 axis in renal cancer cell lines, BMC cancer, 2016.07

Ito H, Ichiyanagi O, Naito S, Bilim V, Tomit Y, Nagaoka A, Tsuchiya N.

Multiple Authorship (Only Japanese)

GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition, BMC CANCER, 16 , 2016.07

Ito, H; Ichiyanagi, O; Naito, S; Bilim, VN; Tomita, Y; Kato, T; Nagaoka, A; Tsuchiya, N

Single Author

LDL CHOLESTEROL COMPROMISES EFFICACY OF MULTITARGETED TYROSINE KINASE INHIBITORS AGAINST RENAL CELL CARCINOMA, JOURNAL OF UROLOGY, 195(4) E1163-E1164, 2016.04

Naito, S; Makhov, P; Kolenko, V; Uzzo, R; Tsuchiya, N

Single Author

Expression of Extracellular Signal-regulated Kinase 5 and Ankyrin Repeat Domain 1 in Composite Pheochromocytoma and Ganglioneuroblastoma Detected Incidentally in the Adult Adrenal Gland, INTERNAL MEDICINE, 55(24) 3611-3621, 2016

Suenaga, S; Ichiyanagi, O; Ito, H; Naito, S; Kato, T; Nagaoka, A; Kato, T; Yamakawa, M; Obara, Y; Tsuchiya, N

Single Author

Utilizing Attributed Graph Representation in Object Detection and Tracking for Indoor Range Sensor Surveillance Cameras, IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS, E98D(12) 2299-2307, 2015.12

Sabirin, H; Sankoh, H; Naito, S

Single Author

A GRIA2 and PAX8-positive renal solitary fibrous tumor with NAB2-STAT6 gene fusion. , Diagnostic pathology, 2015.09

Ichiyanagi O, Ito H, Takai S, Naito S, Kato T, Nagaoka A, Yamakawa M.

Multiple Authorship (Only Japanese)

A GRIA2 and PAX8-positive renal solitary fibrous tumor with NAB2-STAT6 gene fusion, DIAGNOSTIC PATHOLOGY, 10 , 2015.09

Ichiyanagi, O; Ito, H; Takai, S; Naito, S; Kato, T; Nagaoka, A; Yamakawa, M

Single Author

Automatic Soccer Player Tracking in Single Camera with Robust Occlusion Handling Using Attribute Matching, IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS, E98D(8) 1580-1588, 2015.08

Sabirin, H; Sankoh, H; Naito, S

Single Author

Constrained Weighted Least Square Filter for Chrominance Recovery of High Resolution Compressed Image, IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES, E98A(8) 1718-1726, 2015.08

Miyata, T; Yoshino, T; Naito, S

Single Author

Prognosis of Japanese patients with metastatic renal cell carcinoma who underwent subsequent systemic therapy due to prior failure of VEGF-TKI therapy, JOURNAL OF CLINICAL ONCOLOGY, 33(15) , 2015.05

Shinohara, N; Obara, W; Tatsugami, K; Naito, S; Kamba, T; Takahashi, M; Abe, T; Oba, K; Naito, S

Single Author

Prognosis of Japanese patients with previously untreated metastatic renal cell arcinoma in the era of molecular-targeted therapy., Cancer Science, 2015.05

Shinohara N, Obara W, Tatsugami K, Naito S, Kamba T, Takahashi M, Murai S, Abe T, Oba K, Naito S.

Multiple Authorship (Only Japanese)

Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy, CANCER SCIENCE, 106(5) 618-626, 2015.05

Shinohara, N; Obara, W; Tatsugami, K; Naito, S; Kamba, T; Takahashi, M; Murai, S; Abe, T; Oba, K; Naito, S

Single Author

Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma, CANCER BIOLOGY & THERAPY, 16(5) 743-749, 2015.05

Golovine, K; Makhov, P; Naito, S; Raiyani, H; Tomaszewski, J; Mehrazin, R; Tulin, A; Kutikov, A; Uzzo, RG; Kolenko, VM

Single Author

Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma. , Cancer biology & therapy, 2015

Golovine K, Makhov P, Naito S, Raiyani H, Tomaszewski J, Mehrazin R, Tulin A, Kutikov A, Uzzo RG, Kolenko VM.

Multiple Authorship (Only Japanese)

Sunitinib versus sorafenib as first-line therapy for patients with metastatic renal cell carcinoma with favorable or intermediate MSKCC risk factors: A multicenter randomized trial, CROSS-J-RCC., JOURNAL OF CLINICAL ONCOLOGY, 32(4) , 2014.02

Tomita, Y; Naito, S; Sassa, N; Takahashi, A; Kondo, T; Koie, T; Obara, W; Kobayashi, Y; Teishima, J; Takahashi, M; Matsuyama, H; Ueda, T; Yamaguchi, K; Kishida, K; Shiroki, R; Saika, T; Nobuo, S; Oya,...

Single Author

Treatment pattern and prognosis in Japanese patients with metastatic renal cell carcinoma (mRCC) with favorable or intermediate MSKCC risk factors in the era of molecular targeted therapy., JOURNAL OF CLINICAL ONCOLOGY, 32(4) , 2014.02

Shinohara, N; Maruyama, S; Obara, W; Tatsugami, K; Naito, S; Kamba, T; Naito, S

Single Author

Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases; a multicenter study of 556 patients. , Urology, 2013.10

Naito S, Kinoshita H, Kondo T, Shinohara N, Kasahara T, Saito K, Takayama T, Masumori N, Takahashi W, Takahashi M, Terachi T, Ozono S, Naito S, Tomita Y.

Multiple Authorship (Only Japanese)

Prognostic Factors of Patients With Metastatic Renal Cell Carcinoma With Removed Metastases: A Multicenter Study of 556 Patients, UROLOGY, 82(4) 846-851, 2013.10

Naito, S; Kinoshita, H; Kondo, T; Shinohara, N; Kasahara, T; Saito, K; Takayama, T; Masumori, N; Takahashi, W; Takahashi, M; Terachi, T; Ozono, S; Naito, S; Tomita, Y

Single Author

A No Reference Metric of Video Coding Quality Based on Parametric Analysis of Video Bitstream, IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES, E95A(8) 1247-1255, 2012.08

Sugimoto, O; Naito, S; Hatori, Y

Single Author

GSK-3 inhibition <i>in vitro</i> and <i>in vivo</i> enhances antitumor effect of sorafenib in renal cell carcinoma (RCC), BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 423(3) 490-495, 2012.07

Kawazoe, H; Bilim, VN; Ugolkov, AV; Yuuki, K; Naito, S; Nagaoka, A; Kato, T; Tomita, Y

Single Author

GSK-3 inhibition in vitro and vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC)., Biochemical and biophysical research communications, 2012.06

Kawazoe H, Bilim V, Ugolkov A, Yuuki K, Naito S, Nagaoka A, Kato T, Tomita Y.

Multiple Authorship (Including Foreigners)

ESTIMATED GFR AS A BIOMARKER OF EFFICACY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUNITINIB, JOURNAL OF UROLOGY, 187(4) E810, 2012.04

Kato, T; Bilim, V; Nakayama, S; Narisawa, T; Yamagishi, A; Sakurai, T; Nishida, H; Naito, S; Kawazoe, H; Ichiyanagi, O; Nagaoka, A; Tomita, Y

Single Author

PROGNOSTIC FACTORS OF METASTATIC RENAL CELL CARCINOMA PATIENTS WITH REMOVED METASTASES: A MULTICENTER STUDY OF 559 PATIENTS, JOURNAL OF UROLOGY, 187(4) E726, 2012.04

Naito, S; Kinoshita, H; Kondo, T; Shinohara, N; Kasahara, T; Saito, K; Takayama, T; Maumori, N; Terachi, T; Ozono, S; Naito, S; Tomita, Y

Single Author

Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3b. , Cancer Letters, 2012.02

Tsukigi M, Bilim V, Yuuki K, Ugolkov A, Naito S, Nagaoka A, Kato T, Motoyama T, Tomita Y.

Multiple Authorship (Including Foreigners)

Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β, CANCER LETTERS, 315(2) 189-197, 2012.02

Tsukigi, M; Bilim, V; Yuuki, K; Ugolkov, A; Naito, S; Nagaoka, A; Kato, T; Motoyama, T; Tomita, Y

Single Author

Nephrotoxicity induced by VEGF-target agents in patients with metastatic renal cell cancer., JOURNAL OF CLINICAL ONCOLOGY, 30(5) , 2012.02

Kato, T; Nakayama, S; Narisawa, T; Yamagishi, A; Sakurai, T; Naito, S; Kawazoe, H; Ichiyanagi, O; Bilim, V; Nagaoka, A; Tomita, Y

Single Author

IMPACT OF THE NUMBER OF RENAL VESSELS ON THE LAPAROSCOPIC NEPHRECTOMY, JOURNAL OF ENDOUROLOGY, 25 A215, 2011.11

Kato, T; Narisawa, T; Yamagishi, A; Sakurai, T; Nishida, H; Naito, S; Kawazoe, H; Ichiyanagi, O; Nagaoka, A; Tomita, Y

Single Author

THE OUTCOME OF TREATMENT FOR CALCIUM OXALATE STONE IN PROXIMAL URETER WITH EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY IN SOUTHMIYAGI MEDICAL CENTER, JOURNAL OF ENDOUROLOGY, 25 A253, 2011.11

Ichiyanagi, O; Izumi, T; Kawamura, Y; Narisawa, T; Nishida, H; Naito, S; Kawazoe, H; Kato, T; Nagaoka, A; Tomita, Y

Single Author

Glycogen synthase kinase-3 inhibitor and cisplatin synergically inhibit tumor growth of Urothelial cancer in xenograft rodent model, CANCER RESEARCH, 71 , 2011.04

Naito, S; Bilim, V; Kawazoe, H; Tomita, Y

Single Author

LOW MIR-199A EXPRESSION IN RENAL CELL CARCINOMA (RCC) IS RELATED TO MALIGNANT PHENOTYPE VIA UPREGULATION OF GSK-3BETA, JOURNAL OF UROLOGY, 185(4) E49-E50, 2011.04

Tsukigi, M; Bilim, V; Yuuki, K; Ugolkov, A; Naito, S; Kawazoe, H; Sakurai, T; Hosoya, N; Narisawa, T; Nagaoka, A; Kato, T; Oya, M; Motoyama, T; Tomita, Y

Single Author

GLYCOGEN SYNTHASE KINASE INHIBITOR AND CISPLATIN SYNERGICALLY INHIBIT GROWTH OF BLADDER CANCER IN XENOGRAFT RODENT MODEL, JOURNAL OF UROLOGY, 185(4) E212-E213, 2011.04

Naito, S; Bilim, V; Kawazoe, H; Tomita, Y

Single Author

ANALYSIS OF ADVERSE EVENTS ARISING FROM THE USE OF MOLECULAR TARGETED DRUGS IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC) (JAPAN), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41(3) I18, 2011.03

Kato, T; Yamagishi, A; Yagi, M; Nishida, H; Hosoya, N; Sakurai, T; Naito, S; Tsukigi, M; Kawazoe, H; Muto, A; Nagaoka, A; Tomita, Y

Single Author

Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer, CLINICAL CANCER RESEARCH, 16(21) 5124-5132, 2010.11

Naito, S; Bilim, V; Yuuki, K; Ugolkov, A; Motoyama, T; Nagaoka, A; Kato, T; Tomita, Y

Single Author

Glycogen Synthase Kinase-3 beta: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer, CLINICAL CANCER RESEARCH, 2010.11

Naito S, Bilim V, Yuuki K, Ugolkov A, Motoyama T, Nagaoka A, Kato T, Tomita Y

Multiple Authorship (Including Foreigners)

Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro., Anticancer Research, 2010.10

Kato T, Bilim V, Yuuki K, Naito S, Yamanobe T, Nagaoka A, Yano I, Akaza H, Tomita Y.

Multiple Authorship (Only Japanese)

Bacillus Calmette-Guerin and BCG Cell Wall Skeleton Suppressed Viability of Bladder Cancer Cells <i>In Vitro</i>, ANTICANCER RESEARCH, 30(10) 4089-4096, 2010.10

Kato, T; Bilim, V; Yuuki, K; Naito, S; Yamanobe, T; Nagaoka, A; Yano, I; Akaza, H; Tomita, Y

Single Author

DIRECT ANTITUMOR EFFECT OF BACILLUS CALMETTE-GUERIN IN HIGH GRADE UROTHELIAL CANCER CELLS WHICH EXPRESS VLA5 (ALPHA 5 BETA 1 INTEGRIN), JOURNAL OF UROLOGY, 183(4) E445-E446, 2010.04

Kato, T; Yagi, M; Yamagishi, A; Hosoya, N; Sakurai, T; Nishida, H; Naito, S; Tsukigi, M; Kawazoe, H; Muto, A; Nagaoka, A; Tomita, Y

Single Author

Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy, INTERNATIONAL JOURNAL OF UROLOGY, 17(3) 198-205, 2010.03

Kishida, T; Yao, M; Uemura, H; Ohlmann, C; Tomita, Y; Bukowski, RM; Naito, S

Single Author

Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients, EUROPEAN UROLOGY, 2010.02

Naito S, Yamamoto N, Takayama T, Muramoto M, Shinohara N, Nishiyama K, Takahashi A, Maruyama R, Saika T, Hoshi S, Nagao K, Yamamoto S, Sugimura I, Uemura H, Koga S, Takahashi M, Ito F, Ozono S, Terac...

Multiple Authorship (Only Japanese)

Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients, EUROPEAN UROLOGY, 57(2) 317-325, 2010.02

Naito, S; Yamamoto, N; Takayama, T; Muramoto, M; Shinohara, N; Nishiyama, K; Takahashi, A; Maruyama, R; Saika, T; Hoshi, S; Nagao, K; Yamamoto, S; Sugimura, I; Uemura, H; Koga, S; Takahashi, M; Ito, F...

Single Author

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma., British journal of Cancer, 2009.12

Bilim V, Ougolkov A, Yuuki K, Naito S, Kawazoe H, Muto A, Oya M, Billadeau D, Motoyama T, Tomita Y.

Multiple Authorship (Including Foreigners)

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma, BRITISH JOURNAL OF CANCER, 101(12) 2005-2014, 2009.12

Bilim, V; Ougolkov, A; Yuuki, K; Naito, S; Kawazoe, H; Muto, A; Oya, M; Billadeau, D; Motoyama, T; Tomita, Y

Single Author

ROLE OF THE NUCLEAR ACCUMULATION OF GSK-3BETA IN BLADDER CANCER MALIGNANT PHENOTYPE - POTENTIAL THERAPEUTIC TARGET, JOURNAL OF UROLOGY, 181(4) 411, 2009.04

Naito, S; Bilim, V; Yuuki, K; Ougolkov, AV; Billadeau, DD; Motoyama, T; Tomita, Y

Single Author

Vaccination of donors with tumor antigen peptide enhances the antitumor effect on renal tumors in recipient mice with nonmyeloablative allogeneic hemopoietic cell transplantation, JOURNAL OF UROLOGY, 179(4) 37, 2008.04

Eto, M; Hamaguchi, M; Harano, M; Kamiryo, Y; Tatsugrami, K; Takeuchi, A; Naito, S

Single Author

Smac-N7 peptide was more potent than XIAP gene targeting in sensitizing renal cancer cells to apoptotic stimuli, JOURNAL OF UROLOGY, 179(4) 90, 2008.04

Kato, T; Naito, S; Kawazoe, H; Shibasaki, T; Nakano, Y; Yamanobe, T; Kajinuma, A; Muto, A; Vladimir, B; Nagaoka, A; Tomita, Y

Single Author

Inhibition of GSK-3ß activity suppresses the proliferation and induces apoptosis in bladder cancer, JOURNAL OF UROLOGY, 179(4) 369, 2008.04

Naito, S; Yuki, K; Vladimir, B; Shibasaki, T; Kawazoe, H; Nakano, Y; Yamanobe, T; Kajinuma, A; Muto, A; Kato, T; Nagaoka, A; Tomita, Y

Single Author

Real-time multi-scale brain data acquisition, assembly, and analysis using an end-to-end OptIPuter, FUTURE GENERATION COMPUTER SYSTEMS-THE INTERNATIONAL JOURNAL OF ESCIENCE, 22(8) 1032-1039, 2006.10

Singh, R; Schwarz, N; Taesombut, N; Lee, D; Jeong, B; Renambot, L; Lin, AW; West, R; Otsuka, H; Naito, S; Peltier, ST; Martone, ME; Nozaki, K; Leigh, J; Ellisman, MH

Single Author

上部尿路上皮がんにおけるリンパ節郭清の意義 上部尿路上皮がんに対するリンパ節郭清の合併症, 医学図書出版(株), 泌尿器外科, 32(臨増) 661-662, 2019.06

内藤 整, 土谷 順彦

泌尿器腫瘍に対するWhole Body MRI(WB-MRI/DWIBS)の初期経験, 医学図書出版(株), 泌尿器外科, 32(臨増) 761, 2019.06

藤田 英, 内藤 整, 豊口 裕樹, 小澤 迪喜, 福原 宏樹, 八木 真由, 菅野 秀典, 櫻井 俊彦, 西田 隼人, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦

精巣腫瘍に対する化学療法中に血栓症を発症した症例の検討, 医学図書出版(株), 泌尿器外科, 32(臨増) 743, 2019.06

窪木 祐弥, 内藤 整, 菊田 雅斗, 福原 宏樹, 八木 真由, 櫻井 俊彦, 西田 隼人, 山辺 拓也, 加藤 智幸, 土谷 順彦

腎提供前に減量を必要とした生体腎移植ドナーの短期予後の検討, (一社)日本腎臓学会, 日本腎臓学会誌, 61(3) 424, 2019.05

西田 隼人, 山岸 敦史, 福原 宏樹, 櫻井 俊彦, 内藤 整, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦

ロボット支援前立腺全摘術における経直腸超音波ガイド下膀胱頸部離断の有用性の検討, (一社)日本泌尿器科学会総会事務局, 日本泌尿器科学会総会, 107回 PP2-203, 2019.04

櫻井 俊彦, 福原 宏樹, 成澤 貴史, 山岸 敦史, 黒田 悠太, 菅野 秀典, 八木 真由, 西田 隼人, 内藤 整, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦

当院における有転移腎細胞癌患者に対するNivolumab使用経験, (一社)日本泌尿器科学会総会事務局, 日本泌尿器科学会総会, 107回 PP3-168, 2019.04

牛島 正毅, 内藤 整, 小澤 迪喜, 成澤 貴史, 八木 真由, 菅野 秀典, 黒田 悠太, 櫻井 俊彦, 西田 隼人, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦

山形大学における分子標的時代の転移性腎細胞癌長期生存例の検討, (一社)日本泌尿器科学会総会事務局, 日本泌尿器科学会総会, 107回 PP1-167, 2019.04

加藤 智幸, 小澤 迪喜, 福原 宏樹, 成澤 貴史, 八木 真由, 黒田 悠太, 菅野 秀典, 櫻井 俊彦, 西田 隼人, 内藤 整, 川添 久, 山辺 拓也, 土谷 順彦

線維芽細胞増殖因子受容体タイプ4は腎癌薬物療法の新規標的になりうる, (一社)日本泌尿器科学会総会事務局, 日本泌尿器科学会総会, 107回 AOP-095, 2019.04

成澤 貴史, 内藤 整, 伊藤 裕美, 櫻井 俊彦, 一柳 統, 牛島 正毅, 小澤 迪喜, 菅野 秀典, 黒田 悠太, 八木 真由, 山辺 拓也, 加藤 智幸, 土谷 順彦

移植腎生検でBanff score t3i1を認めた症例の短期予後の検討, (一社)日本臨床腎移植学会, 日本臨床腎移植学会プログラム・抄録集, 52回 253, 2019.02

山岸 敦史, 西田 隼人, 福原 宏樹, 成澤 貴史, 八木 真由, 菅野 秀典, 黒田 悠太, 櫻井 俊彦, 内藤 整, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦, 城 謙輔

Trabectedinにより治療効果が得られた脱分化型脂肪肉腫の一例, 医学図書出版(株), 泌尿器外科, 32(1) 87, 2019.01

伊藤 英, 川添 久, 菊田 雅斗, 福原 宏樹, 成澤 貴史, 菅野 秀典, 八木 真由, 山岸 敦史, 櫻井 俊彦, 内藤 整, 西田 隼人, 阿部 明彦, 山辺 拓也, 一柳 統, 加藤 智幸, 土谷 順彦

有転移腎癌における分子標的薬時代の低用量サイトカイン治療, (一社)日本癌治療学会, 日本癌治療学会学術集会抄録集, 56回 P32-6, 2018.10

内藤 整, 菅野 秀紀, 成澤 貴史, 八木 真由, 牛島 正毅, 小澤 迪喜, 加藤 智幸, 土谷 順彦

腎細胞癌におけるアドレナリンβ受容体とカテコールアミン刺激の役割(The role of beta-adrenoceptor and catecholamine stimuli in renal cell carcinoma), 日本癌学会, 日本癌学会総会記事, 77回 2153, 2018.09

牛島 正毅, 一柳 統, 伊藤 裕美, 内藤 整, 成澤 貴史, 八木 真由, 黒田 悠太, 菅野 秀典, 櫻井 俊彦, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦

腎細胞癌においてリン酸化eIF4Eは細胞遊走を抑制し晩期再発を制御する(Phospho-eIF4E prevents tumor recurrence by suppressing epithelial-mesenchymal transition in renal cell carcinoma), 日本癌学会, 日本癌学会総会記事, 77回 1682, 2018.09

伊藤 裕美, 一柳 統, 内藤 整, 菅野 秀典, 成澤 貴史, 黒田 悠太, 金子 紗也香, 牛島 正毅, 小澤 迪喜, 八木 真由, 加藤 智幸, 土谷 順彦

腎細胞癌におけるGSK-3による4EBP1/eIF4E及びMNK1/eIF4Eを介した蛋白質翻訳と細胞増殖制御機構の解析(GSK-3 can affect mRNA translation and proliferation via regulation of 4EBP1/eIF4E and MNK1/eIF4E in renal cell carcinoma), 日本癌学会, 日本癌学会総会記事, 77回 1683, 2018.09

金子 紗也香, 伊藤 裕美, 内藤 整, 成澤 貴史, 黒田 悠太, 菅野 秀典, 八木 真由, 牛島 正毅, 小澤 迪喜, 一柳 統, 加藤 智幸, 土谷 順彦

転移性腎細胞癌患者の末梢血におけるGPI-80発現の臨床的意義(Clinical significance of GPI-80 expression in peripheral blood of metastatic renal cell cancer patients), 日本癌学会, 日本癌学会総会記事, 77回 1681, 2018.09

加藤 智幸, 武田 裕司, 黒田 悠太, 伊藤 裕美, 成澤 貴史, 菅野 秀典, 八木 真由, 櫻井 俊彦, 内藤 整, 川添 久, 山辺 拓也, 浅尾 裕信, 土谷 順彦

腎細胞癌細胞株へのLDL添加による遺伝子発現プロファイリングの変動(Variation of gene expression profiling caused by adding LDL in renal cell carcinoma cell lines), 日本癌学会, 日本癌学会総会記事, 77回 1675, 2018.09

八木 真由, 内藤 整, 伊藤 裕美, 成澤 貴史, 黒田 悠太, 菅野 秀典, 牛島 正毅, 小澤 迪喜, 加藤 智幸, 土谷 順彦

淡明型腎細胞癌におけるFGFR4の機能解析と治療標的としての可能性について(Role of FGFR4 in clear cell renal carinoma and its potential as a new drug target), 日本癌学会, 日本癌学会総会記事, 77回 1435, 2018.09

成澤 貴史, 内藤 整, 伊藤 裕美, 櫻井 俊彦, 小澤 迪喜, 牛島 正毅, 菅野 秀典, 八木 真由, 黒田 悠太, 一柳 統, 加藤 智幸, 土谷 順彦

ラパマイシン耐性腎癌におけるAnkrd1の発現と治療標的の可能性の検討(Ankrd1 as a potential therapeutic target for rapamycin-resistant renal cell carcinoma), 日本癌学会, 日本癌学会総会記事, 77回 1431, 2018.09

小澤 迪喜, 内藤 整, 伊藤 裕美, 牛島 正毅, 成澤 貴史, 菅野 秀典, 黒田 悠太, 八木 真由, 加藤 智幸, 土谷 順彦

mTORC1下流シグナル活性化は非転移性淡明細胞型腎細胞癌の根治術後再発の予測因子となりうる(Activation level of the mTORC1/4EBP1/eIF4E pathway is a predictor for recurrence of clear cell renal cell carcinoma), 日本癌学会, 日本癌学会総会記事, 77回 1432, 2018.09

一柳 統, 伊藤 裕美, 内藤 整, 成澤 貴史, 黒田 悠太, 菅野 秀典, 八木 真由, 櫻井 俊彦, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦

Focal aggressive tubulointerstitial rejectionをきたした症例での短期予後の検討, (一社)日本移植学会, 移植, 53(総会臨時) 375, 2018.09

山岸 敦史, 西田 隼人, 福原 宏樹, 成澤 貴史, 八木 真由, 菅野 秀典, 黒田 悠太, 櫻井 俊彦, 内藤 整, 川添 久, 山辺 拓也, 加藤 智幸, 土谷 順彦, 城 謙輔

細胞核でのERK5発現は腎癌において予後不良因子である(Patients with nuclear expression of ERK5 had poor prognosis in renal cell carcionoma), 日本癌学会, 日本癌学会総会記事, 77回 816, 2018.09

内藤 整, 菅野 秀典, 伊藤 裕美, 加藤 智幸, 一柳 統, 成澤 貴史, 八木 真由, 牛島 正毅, 小澤 迪喜, 黒田 悠太, 櫻井 俊彦, 土谷 順彦

腎癌の脳転移症例についての検討, 医学図書出版(株), 泌尿器外科, 31(臨増) 836, 2018.06

成澤 貴史, 伊藤 英, 菊田 雅斗, 櫻井 俊彦, 内藤 整, 山辺 拓也, 一柳 統, 加藤 智幸, 土谷 順彦

山形大学における腎細胞癌に対するNivolumabの初期使用経験, 医学図書出版(株), 泌尿器外科, 31(臨増) 807, 2018.06

伊藤 英, 内藤 整, 福原 宏樹, 成澤 貴史, 菅野 秀典, 八木 真由, 櫻井 俊彦, 西田 隼人, 川添 久, 阿部 明彦, 一柳 統, 加藤 智幸, 土谷 順彦

悪性腫瘍に対する全身化学療法中に血栓症を発症した症例の検討, 医学図書出版(株), 泌尿器外科, 31(臨増) 862, 2018.06

菊田 雅斗, 一柳 統, 内藤 整, 山辺 拓也, 櫻井 俊彦, 成澤 貴史, 福原 宏樹, 八木 真由, 西田 隼人, 川添 久, 阿部 明彦, 加藤 智幸, 土谷 順彦

mTORC1下流経路活性化が非転移性淡明細胞型腎細胞癌に対する根治切除後の再発時期に及ぼす影響, (一社)日本泌尿器科学会総会事務局, 日本泌尿器科学会総会, 106回 PP2-009, 2018.04

黒川 真行, 一柳 統, 内藤 整, 伊藤 裕美, 菅野 秀典, 成澤 貴史, 櫻井 俊彦, 加藤 智幸, 柿崎 弘, 土谷 順彦

当院における膀胱癌に対する膀胱全摘術についての検討, (一社)日本泌尿器科学会総会事務局, 日本泌尿器科学会総会, 106回 PP3-049, 2018.04

山岸 敦史, 成澤 貴史, 八木 真由, 菅野 秀典, 櫻井 俊彦, 内藤 整, 西田 隼人, 阿部 明彦, 川添 久, 山辺 拓也, 一柳 統, 加藤 智幸, 土谷 順彦

全摘標本から見た前立腺癌に対するマルチパラメトリックMRIの有用性の検討, (一社)日本泌尿器科学会総会事務局, 日本泌尿器科学会総会, 106回 PP1-075, 2018.04

伊藤 英, 内藤 整, 福原 宏樹, 成澤 貴史, 八木 真由, 櫻井 俊彦, 西田 隼人, 阿部 明彦, 川添 久, 山辺 拓也, 一柳 統, 加藤 智幸, 土谷 順彦

Grant-in-Aid for Young Scientists，2018.04 - 2020.03

Grant-in-Aid for Young Scientists(B)，2016.04 - 2018.03